Penile cancer diagnosis and treatment statistics

Patient Experience

Penis cancer patients rating their care very good or excellent, 2014, England

'14-day / Two-week wait'

England meets the standard for their country on the percentage of patients first seen by a specialist within two weeks of urgent GP referral for suspected cancer.[1]

'Two-week wait' supports early diagnosis as spotting cancer early is important for improving survival, so it is important that patients with potential cancer symptoms are referred promptly.

'31-day wait'

None of the countries in the UK meet the standard for their country on the percentage of patients that receive their first cancer treatment within 31 days of a decision to treat.[1-4]

The speed at which patients receive their first treatment can have a positive outcome on their clinical outcome, so it is important that patients with cancer symptoms are treated promptly.

'62-day wait'

None of the countries in the UK meet the standard for their country on the percentage of patients receiving their first definitive treatment for cancer within two months of a GP referral for suspected cancer.[1-4]

The speed at which patients receive their first treatment can have a positive outcome on their clinical outcome, so it is important that patients with cancer symptoms are treated promptly.

Cancer waiting times coding and standards are different in each country and so comparisons should not be made between countries, only each country against their own measures.

Urological Cancers, Waiting Times, UK countries, 2014-15

    England England (testicular cancer only) Wales Scotland Northern Ireland
'14-day wait': seen by specialist following referral Performance 94.3% 97.0%      
Standard 93% 93%      
Performance against standard Meets standard Meets standard      
'31-day wait': receipt of first treatment following decision to treat Performance 95.3% 91.9% 94.0% 90.8% 89.7%
Standard 96% 96% 98% 95% 98%
Performance against standard Does not meet standard Does not meet standard Does not meet standard Does not meet standard Does not meet standard
'62-day wait': receipt of first treatment following referral Performance 78%   85.5% 85.9% 56.1%
Standard 85%   95% 95% 95%
Performance against standard Does not meet standard   Does not meet standard Does not meet standard Does not meet standard

Data for '14-day' and '31-day wait' in England also for testicular cancer separately.

References

  1. NHS England. Cancer waiting times.  Accessed May 2015.
  2. StatsWales. Cancer waiting times. Accessed May 2015. 
  3. ISD Scotland. Cancer Waiting Times. Accessed June 2015. 
  4. Department of Health, Social Services and Public Safety. Cancer Waiting Times. Accessed June 2015.

About this data

Data is for UK, 2014-15, ICD-10 C60-C68

Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Bladder cancer is part of the group 'Urological cancer' for cancer waiting times data. Codes vary per country but broadly include: penis, prostate, testis, other and unspecified male genital organs, kidney, renal pelvis, ureter, bladder, other and unspecified urinary organs, secondary cancers of kidney, renal pelvis, bladder and other unspecified urinary organs.

Last reviewed:

86% of penile cancer patients rate their care as ‘excellent’ or ‘very good’.[1] Patient experience varies with individual needs and concerns, which are influenced by many aspects of personal background, disease characteristics and the care environment.

76% of patients were given the name of a Clinical Nurse Specialist in charge of their care.[1] Being given the name of a Clinical Nurse Specialist in charge of a patients’ care is the factor most likely to be associated with high patient satisfaction scores.[2]

55% said they saw their GP once or twice before being told they had to go to hospital.[1] How often a patient sees their GP before being referred to hospital varies by cancer type depending on ease of diagnosis.[3]

For penile cancer the proportion that said they saw their GP once or twice before being told they had to go to hospital is similar to the average for all cancer patients.[1]

Spotting cancer early is important for improving survival so it is important that patients with potential cancer symptoms are referred for tests promptly.

Penile Cancer (C60), Patient Experience Survey, Males, England, 2014

Male
Percentage of patients treated for cancer who visited their GP once or twice about the health problem caused by their cancer 55.1%
Percentage of patients treated for cancer who said they were given the name of a Clinical Nurse Specialist in charge of their care 75.7%
Percentage of patients treated for cancer who rated their overall care as excellent or very good 86.4%

About this data

Data is for: England, 2014, ICD-10 C60

Patient Experience data is for adult patients in England with a primary diagnosis of cancer and who had been in active treatment between September and November 2013 who completed a survey in 2014.

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.

Rate this page:

Currently rated: 1.7 out of 5 based on 6 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page